For example, Yang et al and Zhao et al reported that miR-126 behaves as a tumor suppressor in osteosarcoma and hepatocellular carcinoma, respectively, by targeting SOX2 [163, 164]. Here, SOX2 is linked to hepatocellular carcinoma.